| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review
|
Cimadamore, Alessia
|
|
|
|
4 |
p. 558-569
|
artikel
|
| 2 |
Adjuvant Radiation Therapy After Radical Nephrectomy in Patients with Localized Renal Cell Carcinoma: A Systematic Review and Meta-analysis
|
Rodríguez-Fernández, Iván A.
|
|
|
|
4 |
p. 448-455
|
artikel
|
| 3 |
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer
|
Faugeroux, Vincent
|
|
|
|
4 |
p. 498-508
|
artikel
|
| 4 |
Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer
|
De Meerleer, Gert
|
|
|
|
4 |
p. 428-429
|
artikel
|
| 5 |
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE)
|
Anttinen, Mikael
|
|
|
|
4 |
p. 635-644
|
artikel
|
| 6 |
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy
|
Salazar, Aina
|
|
|
|
4 |
p. 460-463
|
artikel
|
| 7 |
A Single Educational Seminar Increases Confidence and Decreases Dropout from Active Surveillance by 5 Years After Diagnosis of Prostate Cancer
|
Kinsella, Netty
|
|
|
|
4 |
p. 464-470
|
artikel
|
| 8 |
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer
|
Stabile, Armando
|
|
|
|
4 |
p. 594-600
|
artikel
|
| 9 |
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis
|
Stabile, Armando
|
|
|
|
4 |
p. 519-528
|
artikel
|
| 10 |
A Systematic Review of Intra- and Postoperative Complication Reporting and Grading in Urological Surgery: Understanding the Pitfalls and a Path Forward
|
Soliman, Christopher
|
|
|
|
4 |
p. 378-389
|
artikel
|
| 11 |
Better To Rule In or Rule Out Significant Prostate Cancer? The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography to Magnetic Resonance Imaging Diagnostic Pathways for Prostate Cancer
|
Walz, Jochen
|
|
|
|
4 |
p. 401-402
|
artikel
|
| 12 |
Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials
|
Sonpavde, Guru P.
|
|
|
|
4 |
p. 540-543
|
artikel
|
| 13 |
Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial Cancer
|
Clark-Garvey, Sean
|
|
|
|
4 |
p. 376-377
|
artikel
|
| 14 |
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities
|
Caramelo, Belén
|
|
|
|
4 |
p. 366-375
|
artikel
|
| 15 |
Can Diagnostic Magnetic Resonance Imaging for Suspected Clinically Significant Prostate Cancer Predict Unfavorable Long-term Outcome for Diagnosed Men for Pretreatment Counseling?
|
Schoots, Ivo G.
|
|
|
|
4 |
p. 529-531
|
artikel
|
| 16 |
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States
|
Patel, Hiten D.
|
|
|
|
4 |
p. 343-348
|
artikel
|
| 17 |
Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder
|
Stensland, Kristian D.
|
|
|
|
4 |
p. 509-514
|
artikel
|
| 18 |
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysis
|
Furrer, Marc A.
|
|
|
|
4 |
p. 464-473
|
artikel
|
| 19 |
Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis
|
Cacciamani, Giovanni E.
|
|
|
|
4 |
p. 481-488
|
artikel
|
| 20 |
Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations
|
Hensley, Patrick J.
|
|
|
|
4 |
p. 403-411
|
artikel
|
| 21 |
Contents
|
|
|
|
|
4 |
p. iii-v
|
artikel
|
| 22 |
Contents
|
|
|
|
|
4 |
p. iii-v
|
artikel
|
| 23 |
Contents
|
|
|
|
|
4 |
p. iii-vi
|
artikel
|
| 24 |
Contents
|
|
|
|
|
4 |
p. iii-vi
|
artikel
|
| 25 |
Contents
|
|
|
|
|
4 |
p. iii-iv
|
artikel
|
| 26 |
Contents
|
|
|
|
|
4 |
p. iii-v
|
artikel
|
| 27 |
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review
|
Surov, Alexey
|
|
|
|
4 |
p. 489-497
|
artikel
|
| 28 |
Corrigendum to “Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis” [Eur Urol Oncol 2021;4:927–42]
|
Laukhtina, Ekaterina
|
|
|
|
4 |
p. 480-481
|
artikel
|
| 29 |
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study
|
Erickson, Andrew M.
|
|
|
|
4 |
p. 268-275
|
artikel
|
| 30 |
Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma
|
Lenfant, Louis
|
|
|
|
4 |
p. 464-471
|
artikel
|
| 31 |
Cytoreductive Nephrectomy in the Wake of CARMENA: When to Consider it
|
Sharma, Vidit
|
|
|
|
4 |
p. 379-380
|
artikel
|
| 32 |
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|
Miron, Benjamin
|
|
|
|
4 |
p. 544-547
|
artikel
|
| 33 |
Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer
|
Martini, Alberto
|
|
|
|
4 |
p. 456-463
|
artikel
|
| 34 |
Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes
|
Boeri, Luca
|
|
|
|
4 |
p. 390-396
|
artikel
|
| 35 |
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours
|
Chung, Peter
|
|
|
|
4 |
p. 437-442
|
artikel
|
| 36 |
Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series
|
Tosco, Lorenzo
|
|
|
|
4 |
p. 338-345
|
artikel
|
| 37 |
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer
|
Cani, Andi K.
|
|
|
|
4 |
p. 430-439
|
artikel
|
| 38 |
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
|
Kawada, Tatsushi
|
|
|
|
4 |
p. 390-400
|
artikel
|
| 39 |
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences
|
de Jong, Joep J.
|
|
|
|
4 |
p. 420-423
|
artikel
|
| 40 |
Drug Development for Prostate Cancer with Biochemical Recurrence: Trials and Tribulations
|
Sayegh, Nicolas
|
|
|
|
4 |
p. 553-557
|
artikel
|
| 41 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 42 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 43 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 44 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 45 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 46 |
Editorial Board
|
|
|
|
|
4 |
p. i-ii
|
artikel
|
| 47 |
Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies
|
Pignot, Géraldine
|
|
|
|
4 |
p. 355-364
|
artikel
|
| 48 |
En Bloc Resection of Bladder Tumours: Ready for Clinical Use?
|
Stenzl, Arnulf
|
|
|
|
4 |
p. 449-450
|
artikel
|
| 49 |
En Bloc Versus Conventional Transurethral Resection of Bladder Tumors: A Single-center Prospective Randomized Noninferiority Trial
|
Gallioli, Andrea
|
|
|
|
4 |
p. 440-448
|
artikel
|
| 50 |
ETS Rearrangements, Neuroendocrine Modulators, and Androgen Resistance: What Can the Microenvironment Reveal in Prostate Cancer?
|
Singla, Nirmish
|
|
|
|
4 |
p. 413-414
|
artikel
|
| 51 |
European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update
|
Gakis, Georgios
|
|
|
|
4 |
p. 424-432
|
artikel
|
| 52 |
Feasibility of a Mobile Health Application To Monitor Recovery and Patient-reported Outcomes after Robot-assisted Radical Prostatectomy
|
Belarmino, André
|
|
|
|
4 |
p. 425-428
|
artikel
|
| 53 |
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature
|
Weiner, Adam B.
|
|
|
|
4 |
p. 377-387
|
artikel
|
| 54 |
Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non–muscle-invasive Bladder Cancer
|
Lipunova, Nadezda
|
|
|
|
4 |
p. 381-389
|
artikel
|
| 55 |
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma
|
Zengin, Zeynep B.
|
|
|
|
4 |
p. 447-450
|
artikel
|
| 56 |
Germline BRCA1 Mutation and Prostate Cancer: Be Careful on Causality
|
Boilève, Alice
|
|
|
|
4 |
p. 674-675
|
artikel
|
| 57 |
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?
|
Shariat, Shahrokh
|
|
|
|
4 |
p. 663-669
|
artikel
|
| 58 |
Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer–specific Mortality: Competition Between Age and Time to Biochemical Failure
|
Jackson, William C.
|
|
|
|
4 |
p. 276-282
|
artikel
|
| 59 |
Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis
|
Weinstein, Ilon C.
|
|
|
|
4 |
p. 355-365
|
artikel
|
| 60 |
Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis
|
Tellini, Riccardo
|
|
|
|
4 |
p. 580-593
|
artikel
|
| 61 |
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
|
Maillet, Denis
|
|
|
|
4 |
p. 609-617
|
artikel
|
| 62 |
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database
|
Bandini, Marco
|
|
|
|
4 |
p. 314-320
|
artikel
|
| 63 |
Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?
|
Larcher, Alessandro
|
|
|
|
4 |
p. 365-378
|
artikel
|
| 64 |
Is the Age of Extended Pelvic Lymph Node Dissection Over? The Devil Is in the Details
|
Devos, Gaëtan
|
|
|
|
4 |
p. 540-542
|
artikel
|
| 65 |
Key Perspectives on Managing Older Patients with Prostate Cancer: What We Know About the Fit and What We Need to Know About the Frail
|
Sridhar, Srikala S.
|
|
|
|
4 |
p. 410-411
|
artikel
|
| 66 |
Learning from Our Past Mistakes: A Call for Randomized Controlled Trials in Localized Renal Cell Carcinoma
|
Lawson, Keith A.
|
|
|
|
4 |
p. 453-454
|
artikel
|
| 67 |
Lessons Learned by Pushing the Limits?
|
Thalmann, George N.
|
|
|
|
4 |
p. 305-306
|
artikel
|
| 68 |
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
|
Abu-Ghanem, Yasmin
|
|
|
|
4 |
p. 433-452
|
artikel
|
| 69 |
Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial
|
Touijer, Karim A.
|
|
|
|
4 |
p. 532-539
|
artikel
|
| 70 |
Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study
|
Tetar, Shyama U.
|
|
|
|
4 |
p. 628-634
|
artikel
|
| 71 |
Magnetic Resonance Imaging–based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification
|
Baboudjian, Michael
|
|
|
|
4 |
p. 406-413
|
artikel
|
| 72 |
Magnetic Resonance Imaging–guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate
|
Costa, Daniel N.
|
|
|
|
4 |
p. 397-404
|
artikel
|
| 73 |
Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers
|
Palou, Joan
|
|
|
|
4 |
p. 548-554
|
artikel
|
| 74 |
Managing Prostate Cancer Recurrence After Local Treatment: Balancing Benefits Against Risks in a Rapidly Changing Environment
|
Tombal, Bertrand
|
|
|
|
4 |
p. 388-389
|
artikel
|
| 75 |
Mannose Receptor–positive Macrophage Infiltration Correlates with Prostate Cancer Onset and Metastatic Castration-resistant Disease
|
Zarif, Jelani C.
|
|
|
|
4 |
p. 429-436
|
artikel
|
| 76 |
Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups
|
Hurst, Rachel
|
|
|
|
4 |
p. 412-419
|
artikel
|
| 77 |
Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
|
Cole, Alexander P.
|
|
|
|
4 |
p. 349-354
|
artikel
|
| 78 |
Multiparametric Magnetic Resonance Imaging-targeted Prostate Biopsy: A Plea for a Change in Terminology, and Beyond
|
Giannarini, Gianluca
|
|
|
|
4 |
p. 395-396
|
artikel
|
| 79 |
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy
|
Hemenway, Gregory
|
|
|
|
4 |
p. 431-436
|
artikel
|
| 80 |
New Hormonal Agents in Patients with Nonmetastatic Castration-resistant Prostate Cancer: Can We Be Satisfied with an Advantage in Metastasis-free Survival?
|
Di Nunno, Vincenzo
|
|
|
|
4 |
p. 471
|
artikel
|
| 81 |
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma
|
Martini, Alberto
|
|
|
|
4 |
p. 451-459
|
artikel
|
| 82 |
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response
|
Shafi, Ayesha A.
|
|
|
|
4 |
p. 325-337
|
artikel
|
| 83 |
Pearls to Pivoting a Multidisciplinary Prostate Cancer Survivorship Program During the COVID-19 Pandemic
|
Flannigan, Ryan
|
|
|
|
4 |
p. 397-399
|
artikel
|
| 84 |
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non–muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial
|
Witjes, J. Alfred
|
|
|
|
4 |
p. 307-313
|
artikel
|
| 85 |
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)
|
Morris, Michael J.
|
|
|
|
4 |
p. 543-552
|
artikel
|
| 86 |
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
|
Benziane-Ouaritini, Nicolas
|
|
|
|
4 |
p. 390-398
|
artikel
|
| 87 |
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature
|
Vartolomei, Liliana
|
|
|
|
4 |
p. 283-291
|
artikel
|
| 88 |
Quality Control Indicators for Transurethral Resection of Bladder Tumor: Results from an Embedded Belgian Multicenter Prospective Registry
|
Muilwijk, Tim
|
|
|
|
4 |
p. 422-430
|
artikel
|
| 89 |
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
|
O'Sullivan, Joe M.
|
|
|
|
4 |
p. 455-463
|
artikel
|
| 90 |
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study
|
Karlsson, Questa
|
|
|
|
4 |
p. 570-579
|
artikel
|
| 91 |
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
|
Roussel, Eduard
|
|
|
|
4 |
p. 523-529
|
artikel
|
| 92 |
Re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Kalampokis, Nikolaos
|
|
|
|
4 |
p. 472-473
|
artikel
|
| 93 |
Re: Alberto Martini, Giorgio Gandaglia, R. Jeffrey Karnes, et al. Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer. Eur Urol Oncol 2019;2:456–63
|
Giannarini, Gianluca
|
|
|
|
4 |
p. 472-473
|
artikel
|
| 94 |
Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry
|
Kuppen, Malou C.P.
|
|
|
|
4 |
p. 618-627
|
artikel
|
| 95 |
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press
|
Spratt, Daniel E.
|
|
|
|
4 |
p. 323-324
|
artikel
|
| 96 |
Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182–91
|
Cimadamore, Alessia
|
|
|
|
4 |
p. 671-673
|
artikel
|
| 97 |
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038
|
Mollica, Veronica
|
|
|
|
4 |
p. 559-560
|
artikel
|
| 98 |
Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519–25
|
Montorsi, Francesco
|
|
|
|
4 |
p. 451
|
artikel
|
| 99 |
Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002
|
Guler, Ozan Cem
|
|
|
|
4 |
p. 475-476
|
artikel
|
| 100 |
Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution
|
Bravi, Carlo Andrea
|
|
|
|
4 |
p. 474-480
|
artikel
|
| 101 |
Reply to Nikolaos Kalampokis, Nikolaos Grivas, Markos Karavitakis, and Henk van der Poel’s Letter to the Editor re: Aina Salazar, Lucas Regis, Jacques Planas, et al. A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy. Eur Urol Oncol 2022;5:460–3
|
Morote, Juan
|
|
|
|
4 |
p. 474
|
artikel
|
| 102 |
Reply to Ozan Cem Guler and Cem Onal’s Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.04.005
|
Pan, Jian
|
|
|
|
4 |
p. 479
|
artikel
|
| 103 |
Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54
|
Guler, Ozan Cem
|
|
|
|
4 |
p. 477-478
|
artikel
|
| 104 |
Re: Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol 2020;3:306–315
|
Glykas, Ioannis
|
|
|
|
4 |
p. 555-556
|
artikel
|
| 105 |
Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125–35
|
Rizzo, Alessandro
|
|
|
|
4 |
p. 670
|
artikel
|
| 106 |
Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol 2020;77:713–724
|
Rakic, Nikola
|
|
|
|
4 |
p. 557-558
|
artikel
|
| 107 |
Re: Toni K. Choueiri, Daniel Y.C. Heng, Jae Lyun Lee, et al. Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2020.2218
|
Mollica, Veronica
|
|
|
|
4 |
p. 561-562
|
artikel
|
| 108 |
“Reverse Stage Migration”: What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?
|
Wallis, Christopher J.D.
|
|
|
|
4 |
p. 321-322
|
artikel
|
| 109 |
Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review
|
Shevach, Jeffrey W.
|
|
|
|
4 |
p. 400-409
|
artikel
|
| 110 |
Risk of Depression After Radical Prostatectomy—A Nationwide Registry-based Study
|
Friberg, Anne Sofie
|
|
|
|
4 |
p. 601-608
|
artikel
|
| 111 |
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes
|
Satkunasivam, Raj
|
|
|
|
4 |
p. 443-447
|
artikel
|
| 112 |
Robotic Postchemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer
|
Li, Roger
|
|
|
|
4 |
p. 651-658
|
artikel
|
| 113 |
Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition
|
Lam, Jie M.
|
|
|
|
4 |
p. 659-662
|
artikel
|
| 114 |
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients
|
Psutka, Sarah P.
|
|
|
|
4 |
p. 292-304
|
artikel
|
| 115 |
Stereotactic Radiotherapy for Lesions Detected via 68Ga-Prostate-specific Membrane Antigen and 18F-Fluorodexyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study
|
Pan, Jian
|
|
|
|
4 |
p. 420-427
|
artikel
|
| 116 |
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis
|
Nazzani, Sebastiano
|
|
|
|
4 |
p. 346-351
|
artikel
|
| 117 |
Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study
|
Grünwald, Viktor
|
|
|
|
4 |
p. 437-446
|
artikel
|
| 118 |
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium
|
Donskov, Frede
|
|
|
|
4 |
p. 530-539
|
artikel
|
| 119 |
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
|
Ali, Adnan
|
|
|
|
4 |
p. 412-419
|
artikel
|
| 120 |
The Cost to Medicare of Bladder Cancer Care
|
Sloan, Frank A.
|
|
|
|
4 |
p. 515-522
|
artikel
|
| 121 |
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy
|
Patel, Neal
|
|
|
|
4 |
p. 263-267
|
artikel
|
| 122 |
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
|
Pasquier, David
|
|
|
|
4 |
p. 399-405
|
artikel
|
| 123 |
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy
|
Bravi, Carlo A.
|
|
|
|
4 |
p. 414-421
|
artikel
|
| 124 |
Toward Individualized Approaches to Partial Nephrectomy: Assessing the Correlation Between Ischemia Time and Patient Health Status (RECORD2 Project)
|
Bravi, Carlo Andrea
|
|
|
|
4 |
p. 645-650
|
artikel
|
| 125 |
Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer
|
Shinde, Dheeraj
|
|
|
|
4 |
p. 415-424
|
artikel
|
| 126 |
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications
|
Alshalalfa, Mohammed
|
|
|
|
4 |
p. 405-412
|
artikel
|
Tijdschrift beschrijving